Chatterjee, #6, Implemeting adapted version of Kaiser's HTN control protocol in GMC

Chatterjee, #6, Implemeting adapted version of Kaiser's HTN control protocol in GMC

by Purba Chatterjee -

1) What level of government did you target to translate your research into policy and why did this make the most sense?

I didn’t target any government agency yet but if the implementation of the adapted Kaiser HTN control protocol is successful in GMC, we would like to scale implementation to the CHN clinics and the SF Health Plan.  To do this, I would have to target the San Francisco City and County government agencies.

2) What level of government makes the most sense for you to translate your research into policy and why?

Once again, the city and county of San Francisco would make most sense for scalability of this initiative.

3) What strategies did you use to reach policymakers? 

Appropriate strategies would include:

    • Evidence that protocol is effective
    • Scalable and sustainable
    • Cost effective
    • Improved patient outcomes

4) What steps are available to you to reach policymakers?

I am working with very influential stakeholders and partners on this project. If we can show implementing this new protocol is highly effective in improving patient outcomes, reducing costs, and is scalable, then stakeholders and project partners are likely to facilitate connections with policy makers.

I would also use our extensive social media network to highlight success stories. We would also develop a detailed evaluation plan and work on publishing and widely disseminating the results to policy makers.

 

 

                                                                                                                                

Re: Chatterjee, #6, Implemeting adapted version of Kaiser's HTN control protocol in GMC

by Ralph Gonzales -

Hi Purba,

Planning on how to incorporate policy at a later stage could help refine your current implementation strategy.  So that  if you need SF City and Gov’t Agencies to support spread to CHN and SF Health Plan, it would be worthwhile to meet with their representatives now in order to make sure you are measuring the outcomes that they care about, and have a sense for what “effect size” they need to move forward with a dissemination. 

 Re: Strategies:  I would also encourage you to engage and “listen” to policymakers about what goals they have for improving the health of your target population. Hypertension may not be on their radar screen, in which case you will need to frame your data/evidence to show them why they should support an effective intervention.  Conversely, they may already be on-board, in which case you make sure they know about you and your program b/c they may be pursuing a program independently from yours—and you’d hate to have redundancy.

Re: Chatterjee, #6, Implemeting adapted version of Kaiser's HTN control protocol in GMC

by Brian -

Hi Purba-

Really interesting project and as a GMC'er will be interested to see this implemented. One thought I had about policymaker engagement in implementing this is to reach policymakers (i'm not sure who local/state) who have influence on the formulary deciders-- I could see a scenario where implementation of the HTN protocol is hampered by MDs having to fill out prior authorizations/get more approval for medications (or lab testing/payment for counciling, etc) on the protocol. --B

Re: Chatterjee, #6, Implemeting adapted version of Kaiser's HTN control protocol in GMC

by Purba Chatterjee -

Thanks Brian! Really good points.

With regards to medications - we have already checked the formulary to ensure that all the medications suggested in the new protocol, especially fixed dose combination pills, are already available in the formulary.

The new protocol does not require additional lab visits but something definitely to keep in mind.

Thanks!

-purba